| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 21,096 | 31,942 | ||
| Prepaid expenses and other current assets | 3,178 | 1,721 | ||
| Total current assets | 24,274 | 33,663 | ||
| Property and equipment, net | 603 | 657 | ||
| Right-of-use assets | - | 1,507 | ||
| Other long-term assets | 144 | 226 | ||
| Total assets | 25,021 | 36,053 | ||
| Current portion of contingent consideration | - | 1,603 | ||
| Accounts payable | 917 | 658 | ||
| Accrued expenses and other current liabilities | 2,826 | 3,838 | ||
| Current portion of lease liabilities | 420 | 406 | ||
| Current portion of long-term debt | 28,411 | 9,511 | ||
| Long-term debt, net of current portion | - | 18,786 | ||
| Total current liabilities | 32,574 | 16,016 | ||
| Long-term lease liabilities | 1,112 | 1,227 | ||
| Long-term contingent consideration | - | 3,230 | ||
| Total long-term liabilities | 1,112 | 23,243 | ||
| Total liabilities | 33,686 | 39,259 | ||
| Common stock, 0.001 par value 120,000,000 shares authorized as of september 30, 2025 and december 31, 2024 7,432,925 and 6,091,182 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 7 | 7 | ||
| Additional paid-in capital | 686,914 | 684,809 | ||
| Accumulated deficit | -695,586 | -688,022 | ||
| Total stockholders' (deficit) equity | -8,665 | -3,206 | ||
| Total liabilities and stockholders' equity | 25,021 | 36,053 | ||
KALA BIO, Inc. (KALA)
KALA BIO, Inc. (KALA)